Argo Biopharma to Present Positive Phase II Interim Results of siRNA Therapeutic BW-20805 for HAE at the 2026 AAAAI Annual Meeting
-Poster Presentation Selected as Late Breaking Abstract- SHANGHAI and BOSTON, Feb. 25, 2026 /PRNewswire/ — Argo Biopharmaceutical Co., Ltd. (Argo…
